Sub Banner Image

Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?

Equities

Zacks Investment Research, Inc.

·

August 1, 2025

·

Barchart

Clover Health Investments CLOV is slated to release second-quarter 2025 results on Aug. 5, after market close. The Zacks Consensus Estimate for earnings and revenues is pegged at 3 cents per share and $482.5 million, respectively.The earnings estimate, which has remained stable over the past 30 days, indicates a whopping...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.